Trials / Sponsors / NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization Staphylococcus Aureus | Phase 2 | 2018-01-30 |
| Completed | Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candi Vulvovaginal Candidiasis | Phase 1 / Phase 2 | 2013-07-01 |
| Completed | Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine Staphylococcal Infections, Yeast Infections, Candidiasis | Phase 1 | 2011-09-01 |
| Completed | Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida Staphylococcal Infections, Candidiasis | Phase 1 | 2011-01-01 |